Zobrazeno 1 - 10
of 525
pro vyhledávání: '"Anthony, Chan"'
Autor:
Zonghao Li, Anthony Chan Carusone
Publikováno v:
IEEE Access, Vol 12, Pp 150032-150045 (2024)
This paper presents a fully open-sourced AMS integrated circuit optimization framework based on reinforcement learning (RL). Specifically, given a certain circuit topology and target specifications, this framework optimizes the circuit in both schema
Externí odkaz:
https://doaj.org/article/9dd4790acacb4f449b20f852e1205f2a
Autor:
Chieko Kurihara, Sandor Kerpel-Fronius, Sander Becker, Anthony Chan, Yasmin Nagaty, Shehla Naseem, Johanna Schenk, Kotone Matsuyama, Varvara Baroutsou
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
The World Medical Association’s Declaration of Helsinki is in the process of being revised. The following amendments are recommended to be incorporated in pursuit of the common goal of promoting health for all. 1. Data-driven research that facilita
Externí odkaz:
https://doaj.org/article/6d750be978884dbaac5f734386e9ba45
Autor:
Jason Chung, Owais Mian, Ivan Stevic, Sajjad Afraz, Anthony Chan, Howard Chan, Bret M. Evers, Davide Matino
Publikováno v:
Thrombosis Update, Vol 14, Iss , Pp 100163- (2024)
Externí odkaz:
https://doaj.org/article/5c3e90eaeebb4a75bcaeb3f8a55b722e
Autor:
Anil Kumar, Min Huang, Norman J. Lacayo, Holden T. Maecker, Stephen J. Forman, Srividya Swaminathan, Caroline Duault, Jianhua Yu, Steven T. Rosen, Anthony Chan, Martin Carroll, Adeleh Taghi Khani, Soraya Aramburo, Ashly Sanchez Ortiz, Sung June Lee, Tinisha McDonald, Kathleen M. Sakamoto, Christian Hurtz, Sarah K. Tasian, Lucy Ghoda, Guido Marcucci, Zhaohui Gu, Saro Armenian, Shai Izraeli, Chun-Wei Chen, Michael A. Caligiuri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
Background Type I interferons (IFN-Is), secreted by hematopoietic cells, drive immune surveillance of solid tumors. However, the mechanisms of suppression of IFN-I-driven immune responses in hematopoietic malignancies including B-cell acute lymphobla
Externí odkaz:
https://doaj.org/article/fe41859c6f9543c091bbe4f40f81980e
Publikováno v:
Frontiers in Research Metrics and Analytics, Vol 8 (2023)
IntroductionFruit losses in the supply chain owing to improper handling and a lack of proper control are common in the industry. As losses are caused by the inefficiency of the export method, selecting the appropriate export method is a possible solu
Externí odkaz:
https://doaj.org/article/07e4f6204f794182ae93126b327996b3
Publikováno v:
IEEE Access, Vol 10, Pp 122061-122073 (2022)
This paper elucidates the relative benefits of bit loading and power loading for discrete multitone (DMT) modulation over wireline links. There is considerable variability in the use of bit and power loading in recent research on DMT for wireline app
Externí odkaz:
https://doaj.org/article/de94ae717e264404847b875f805d2919
Publikováno v:
IEEE Open Journal of Circuits and Systems, Vol 3, Pp 216-227 (2022)
This paper provides a framework for analyzing the loop dynamics of the clock and data recovery (CDR) system of ADC-based PAM-4 receivers, which will assist in extending the timing recovery loop bandwidth. This paper formulates an accurate linear mode
Externí odkaz:
https://doaj.org/article/02462b5557be40d587f17c40daaabc6f
Publikováno v:
IEEE Access, Vol 10, Pp 50403-50417 (2022)
This paper presents a method to estimate the internal impairment parameters of broadband time-interleaved (TI) ADCs using only single-tone measurement data acquired at two different frequencies. The estimated parameters, which include the signal-inde
Externí odkaz:
https://doaj.org/article/30229b29422f43e8a37f4bd8a7be5cc2
Autor:
Talan Tran, Claudia Cruz, Anthony Chan, Salma Awad, Johnson Rajasingh, Richard Deth, Narasimman Gurusamy
Publikováno v:
Cells, Vol 12, Iss 18, p 2268 (2023)
Cardiac injury, such as myocardial infarction and heart failure, remains a significant global health burden. The limited regenerative capacity of the adult heart poses a challenge for restoring its function after injury. Mesenchymal stem cells (MSCs)
Externí odkaz:
https://doaj.org/article/8f8e4eda217d42aca30ae03a0d6631d8
Autor:
Rob S. Sellar, Adam S. Sperling, Mikołaj Słabicki, Jessica A. Gasser, Marie E. McConkey, Katherine A. Donovan, Nada Mageed, Dylan N. Adams, Charles Zou, Peter G. Miller, Ravi K. Dutta, Steffen Boettcher, Amy E. Lin, Brittany Sandoval, Vanessa A. Quevedo Barrios, Veronica Kovalcik, Jonas Koeppel, Elizabeth K. Henderson, Emma C. Fink, Lu Yang, Anthony Chan, Sheela Pangeni Pokharel, Erik J. Bergstrom, Rajan Burt, Namrata D. Udeshi, Steven A. Carr, Eric S. Fischer, Chun-Wei Chen, Benjamin L. Ebert
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 16 (2022)
Targeted protein degradation is a rapidly advancing and expanding therapeutic approach. Drugs that degrade GSPT1 via the CRL4CRBN ubiquitin ligase are a new class of cancer therapy in active clinical development with evidence of activity against acut
Externí odkaz:
https://doaj.org/article/81fae13f3404407c97508eb3a6337c9d